Moyamoya Angiopathy in Europe

  • Yasuhiro Yonekawa
  • Javier Fandino
  • Martina Hug
  • Markus Wiesli
  • Masayuki Fujioka
  • Nadia Khan


This chapter deals with moyamoya angiopathy (MMA) [1, 2], [moyamoya disease (MMD), moyamoya syndrome (MMS), and unilateral MM pathology] in Europe. Although this terminology MMA might give rise to some objections, it is considered to be acceptable from the clinical and practical points of view [2, 3], as the senior author (Y.Y.) has experience of a considerable number of patients with this pathology in Japan and in Europe (Zürich). As knowledge of recent investigation on its pathophysiology and etiology has been outlined elsewhere [2], we focus our attention here on our clinical experience in Zürich and attempt to clarify some differences between MMA in Europe and in Japan.


Positron Emission Tomography Anterior Cerebral Artery Posterior Cerebral Artery Moyamoya Disease Superficial Temporal Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors are indebted to Ms. R. Frick for secretarial work and Mr. P. Roth for artistic drawings. They are also grateful for the excellent cooperative work to: Prof. E. Boltshauser, Prof. A. Buck, Prof. A. Valavanis and Prof. B. Schuknecht.


  1. 1.
    Yonekawa Y, Khan N (2003) Moyamoya disease. In: Barnett HJM, Bogousslavsky J, Meldrum H (eds) Ischemic stroke: advances in neurology, vol 92. Lippincott Williams & Wilkins, Philadelphia, pp 113–118Google Scholar
  2. 2.
    Yonekawa Y, Takagi Y, Khan N (2009) Adult moyamoya disease. In: Winn HR (ed) Youman's neurological surgery, 6th edition. Elsevier (in press)Google Scholar
  3. 3.
    Peerless SJ (1997) Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg 99(Suppl 2):45–48CrossRefGoogle Scholar
  4. 4.
    Yonekawa Y, Goto Y, Ogata N (1992) Moyamoya disease: diagnosis, treatment, and recent achievement. Part IV. Specific medical disease and stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds) Stroke, pathophysiology, diagnosis and management. Churchill Livingstone, New York, pp 721–747Google Scholar
  5. 5.
    Fukui M, Members of Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease) of the Ministry of Health and Welfare, Japan (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya’ disease). Clin Neurol Neurosurg 99(Suppl 2):S238–S240PubMedGoogle Scholar
  6. 6.
    Yonekawa Y (2009) Brain revascularization by extracranial intracranial arterial bypass. In: Sindou M (ed) Practical handbook of neurosurgery, vol 1. Springer, Wien, pp 355–381CrossRefGoogle Scholar
  7. 7.
    Khan N, Schuknecht B, Boltshauser E et al (2003) Moyamoya disease and moyamoya syndrome: experience in Europe: choice of revascularisation procedures. Acta Neurochir (Wien) 145:1061–1071CrossRefGoogle Scholar
  8. 8.
    Takeuchi K, Shimuzu K (1957) Hypoplasia of the bilateral internal carotid arteries. No To Shinkei 9:37–43Google Scholar
  9. 9.
    Suzuki J, Takaku (1969) Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRefGoogle Scholar
  10. 10.
    Kudo T (1968) Spontaneous occlusion of the circle of Willis: a disease apparently confined to Japanese. Neurology 18:485–496PubMedCrossRefGoogle Scholar
  11. 11.
    Kodama N, Fujiwara S, Hone Y et al (1980) Transdural anastomosis in moyamoya disease: vault moyamoya. No Shinkei Geka 8:729–739PubMedGoogle Scholar
  12. 12.
    Suzuki J, Kodama N (1971) Cerebrovascular “moyamoya” disease. Second report. Collateral routes to forebrain via ethmoidal sinus and superior nasal meatus. Angiology 23:233–236Google Scholar
  13. 13.
    Goto Y, Yonekawa Y (1992) Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32:883–886CrossRefGoogle Scholar
  14. 14.
    Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900–904PubMedCrossRefGoogle Scholar
  15. 15.
    Uchino K, Johnston SC, Becker KJ et al (2005) Moyamoya disease in Washington State and California. Neurology 65:956–958PubMedCrossRefGoogle Scholar
  16. 16.
    Yonekawa Y, Ogata N, Kaku Y et al (1997) Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99(Suppl 2):S58–60PubMedCrossRefGoogle Scholar
  17. 17.
    Fodstad H, Bodosi M, Forsell A et al (1996) Moyamoya disease in Finno-Uguric origin. Br J Neurosurg 10:179–186PubMedCrossRefGoogle Scholar
  18. 18.
    Isler W (1991) Moyamoya disease in Europe. In: Yonekawa Y (ed) Annual Report of Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease) of the Ministry of Welfare and Health, Japan 1990. Tokyo, pp 16–21Google Scholar
  19. 19.
    Kawano T, Fukui M, Hashimoto N et al (1994) Follow-up study of patients with “unilateral” moy-amoya disease. Neurol Med Chir (Tokyo) 34:744–747CrossRefGoogle Scholar
  20. 20.
    Kraemer M, Heienbrok W, Berlit P (2008) Moyamoya disease in Europeans. Stroke 39:3193–3200PubMedCrossRefGoogle Scholar
  21. 21.
    Czabanka M, Vajkoczy P, Schmiedek P et al (2009) Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population. Neurosurg Focus 26(4):E9PubMedCrossRefGoogle Scholar
  22. 22.
    Fukuyama Y, Sugawara N, Osawa M (1991) A genetic study of idiopathic spontaneous occlusion of the circle of Willis. In: Yonekawa Y (ed) Annual Report of Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease) of the Ministry of Welfare and Health, 1990. Tokyo, pp 139–144Google Scholar
  23. 23.
    Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237PubMedCrossRefGoogle Scholar
  24. 24.
    Hallemeier CL, Rich KM, Grubb RL et al (2006) Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:1490–1946PubMedCrossRefGoogle Scholar
  25. 25.
    Handa H, Yonekawa Y (1985) Analysis of filing data bank of 1500 cases of spontaneous occlusion of the circle of Willis and study of 200 cases for more than 5 years. Stroke (Tokyo) 7:477–480Google Scholar
  26. 26.
    Chiu D, Shedden P, Bratina P et al (1998) Clinical features of moyamoya disease in the United States. Stroke 29:1347–1351PubMedCrossRefGoogle Scholar
  27. 27.
    Miyamoto S, Kikuchi H, Karasawa J et al (1984) Study of the posterior circulation in moyamoya disease. Clinical and neuroradiological evaluation. J Neurosurg 61:1032–1037PubMedCrossRefGoogle Scholar
  28. 28.
    Kawaguchi S, Sakaki T, Kakizaki T et al (1996) Clinical features of the haemorrhage type moy-amoya disease based on 31 cases. Acta Neurochir (Wien) 138:1200–1210CrossRefGoogle Scholar
  29. 29.
    Kawaguchi S, Sakaki T, Morimoto T et al (1996) Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir (Wien) 138:1287–1294CrossRefGoogle Scholar
  30. 30.
    Donaghy RM, Yasargil G (1968) Extracranial blood flow diversions in microvascular surgery. The 36th Annual Meeting of the American Association of Neurological Surgeons, Chicago, IiinoisGoogle Scholar
  31. 31.
    Yasargil MG (1969) Microsurgery applied to neurosurgery. Thieme, StuttgartGoogle Scholar
  32. 32.
    Henschen C (1950) Operative revascularization des zirkulatorisch geschädigten Gehirns durch Auflage gestielten Muskellappen (Encephalo-myo-synangiose). Langenbecks Arch Klein Chir 264:392–401CrossRefGoogle Scholar
  33. 33.
    Matsushima Y, Fukai N, Tanaka K et al (1981) A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol 15(4):313–320PubMedCrossRefGoogle Scholar
  34. 34.
    Yonekawa Y, Handa H, Moritake K et al (1985) Revascualrization in children with moyamoya disease: low-density area and regional cerebral blood flow after operation. In: Handa H, Kikuchi H, Yonekawa Y (eds) Microsurgical anastomosis for cerebral ischemia. Igaku-shoin, Tokyo, pp 272–274Google Scholar
  35. 35.
    Fujimura M, Kaneta T, Mugikura S et al (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273–282PubMedCrossRefGoogle Scholar
  36. 36.
    Iwama T, Hashimoto N, Miyake H et al (1998) Direct revascularization to the anterior cerebral artery territory in patients with moyamoya disease. Report of five cases. Neurosurgery 42:1157–1161PubMedCrossRefGoogle Scholar
  37. 37.
    Tanaka K, Yonekawa Y, Satou K et al(1992) STA—ACA anastomosis with interposed vein graft. A case report. No Shinkei Geka (Tokyo) 20:171–176Google Scholar
  38. 38.
    Yonekawa Y, Imhof HG, Taub E et al (2001) Supracerebellar transtentorial approach for posterior temporomedial structures. J Neurosurg 94:339–345PubMedCrossRefGoogle Scholar
  39. 39.
    Muroi C, Yonekawa Y, Khan N et al (2003) Case report. Metabolic changes after H215O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases. J Neurosurg Anesthiol 15:131–139CrossRefGoogle Scholar
  40. 40.
    Iwama T, Hashimoto N, Yonekawa Y (1996) The relevance of hemodynamic factors in perioperative complications in childhood moyamoya disease. Clinical studies. Neurosurgery 38:1120–1126PubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Yasuhiro Yonekawa
    • 1
    • 2
    • 3
    • 4
  • Javier Fandino
    • 2
  • Martina Hug
    • 3
  • Markus Wiesli
    • 4
  • Masayuki Fujioka
    • 1
    • 2
  • Nadia Khan
    • 5
  1. 1.University of ZürichZürichSwitzerland
  2. 2.Department of NeurosurgeryKantonsspital AarauTellstrasseSwitzerland
  3. 3.Children's Hospital of ZürichUniversity ClinicZürichSwitzerland
  4. 4.Klinik im ParkZürichSwitzerland
  5. 5.Department of Neurosurgery and Stanford Stroke CenterStanford University School of MedicineStanfordUSA

Personalised recommendations